-
Rituximab, sold
under the
brand name
Rituxan among others, is a
monoclonal antibody medication used to
treat certain autoimmune diseases and
types of...
-
antibodies such as
rituximab,
which are
increasingly being used as first-line treatment. In
summer 2018, the FDA
granted full
approval to
rituximab for this application...
- of t-FL (e.g., the
addition to
standard chemotherapy of
agents such as
rituximab) have
improved overall survival times.
These newer regimens may also delay...
- 90% to less than 20%. Immunosuppressants, such as glucocorticoids, and
rituximab may also be used.
Platelet transfusions are
generally not recommended...
- use corticosteroids.[citation needed] The anti-CD20
monoclonal antibody rituximab has been
found to be
effective in
treating some
otherwise refractory cases...
- as
rituximab or
cyclophosphamide and high-dose
corticosteroids to
control the
symptoms of the
disease and azathioprine, methotrexate, or
rituximab to...
- (more than 3
years if
combined with
rituximab),
after which remission occurs. BRAF
inhibitors with or
without rituximab may be
restarted if
there is relapsed...
-
follicular lymphoma as a
second line
treatment to a
regimen containing rituximab.
Obinutuzumab was not
tested in
pregnant women.
Obinutuzumab has two black...
-
promise in this
technique treating anti-MAG neuropathies.[citation needed]
Rituximab is
considered to be one of the most
promising drugs in the
treatment of...
-
treatment with
ibrutinib and
rituximab showed significantly higher disease progression-free
survival than
treatment with
rituximab alone.
Autologous bone marrow...
